A Study of IMR-687 in Subjects With Beta Thalassemia
Clinical trial NCT04411082 · TERMINATED
Trial details
- NCT number
- NCT04411082
- Sponsor
- Cardurion Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-16
- Primary completion
- 2022-03-11
- Enrollment
- 122
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.